Table 2.
Demographic data for focus group participants
| Group 1 (n = 7) |
Group 2 (n = 8) |
Group 3 (n = 8) |
Group 4 (n = 6) |
Overall 1–4 (n = 29) |
|
|---|---|---|---|---|---|
| Female (no.) | 5 | 5 | 7 | 6 | 23 |
| Duration RA, years mean (IQR) | 8 | 15.4 | 16.7 | 9 | 12.3 (4–10) |
| Erosive disease (no.) | 1 | 4 | 4 | 4 | 13 |
| Medication | |||||
| DMARD use (no.) | 7 | 7 | 7 | 5 | 26 |
| Biological use (no.) | 2 | 6 | 3 | 3 | 14 |
| Age, years (mean, SD) | 57.5 | 56.1 | 58.7 | 55.2 | 56.8 (8.9) |
| VAS fatigue 0–100 (mean, SD) | 67 (12.8) | ||||
| HAQ, 0–3 (mean, SD) | 1.1 (0.6) | ||||
| RADAI, 0–10 (mean, SD) | 2.7 (1.8) |